Markets /Healthcare /NYMX Nymox Pharmaceutical Corporation NYMX Full chart Compare Add to watchlist Set alert Price alert · NYMX Alert when the price is Price abovePrice below Price level Set alert All alert types 0.20 +0.20 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2020FY 2019FY 2018 Revenue → Gross Profit: $1.00KGross Profit → Expenses: $1.00KRevenue → Cost of Revenue: $4.00KExpenses → Selling, General & Admin: $3.60MExpenses → Research & Development: $8.12MExpenses → Other Expenses: $18.00KExpenses → Income Tax: $42.00KNet Loss → Expenses: $11.78MGross Profit$1.00KNet Loss$11.78MCost of Revenue$4.00KExpenses$11.78MSelling, General & Admin$3.60MResearch & Development$8.12MOther Expenses$18.00KIncome Tax$42.00KRevenue$5.00K No annual statement lines NYMX has no annual lines for this statement.
